(Q46629483)

23 December 2017

title

Seroprevalence of viral childhood infections in Eritrea (English)

1 reference

23 December 2017

0 references

1 reference

1

1 reference

23 December 2017

author name string

Enbom M

2

1 reference

23 December 2017

Ghebrekidan H

3

1 reference

23 December 2017

Rudén U

4

1 reference

23 December 2017

Linde A

5

1 reference

23 December 2017

Grandien M

6

1 reference

23 December 2017

Wahren B

7

1 reference

23 December 2017

publication date

1 February 2000

1 reference

23 December 2017

Journal of Clinical Virology

published in

1 reference

23 December 2017

volume

16

1 reference

23 December 2017

issue

1

1 reference

23 December 2017

page(s)

49-54

1 reference

23 December 2017

Role of parvovirus B19 in human disease

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2899%2900070-0

7 January 2021

An outbreak of erythema infectiosum associated with human parvovirus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2899%2900070-0

7 January 2021

Geographic variation in infant loss of maternal measles antibody and in prevalence of rubella antibody

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2899%2900070-0

7 January 2021

Plaque-associated expression of human herpesvirus 6 in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2899%2900070-0

7 January 2021

The prevalence of antibody to human parvovirus B19 in England and Wales

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2899%2900070-0

7 January 2021

Parvovirus-like particles in human sera

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2899%2900070-0

7 January 2021

Hepatitis due to human herpesvirus-6

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2899%2900070-0

7 January 2021

Seroprevalence of human herpes virus 8 in different Eritrean population groups

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2899%2900070-0

7 January 2021

Prevalence of human parvovirus (B19) and rubella virus infections in urban and remote rural areas in northern Brazil

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2899%2900070-0

7 January 2021

Prevalence of infection with HIV, hepatitis B and C viruses, in four high risk groups in Eritrea

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2899%2900070-0

7 January 2021

Prevalence of herpes simplex virus types 1 and 2, cytomegalovirus, and varicella-zoster virus infections in Eritrea

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2899%2900070-0

7 January 2021

Parvovirus infections in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2899%2900070-0

7 January 2021

Measles in Africa: a deadly disease. Some personal comments

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2899%2900070-0

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2899%2900070-0

7 January 2021

Immunoglobulin class and immunoglobulin G subclass enzyme-linked immunosorbent assays compared with microneutralization assay for serodiagnosis of mumps infection and determination of immunity.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2899%2900070-0

7 January 2021

IgG antibodies to human herpesvirus-6 in children and adults and in primary Epstein-Barr virus infections and cytomegalovirus infections [corrected]

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2899%2900070-0

7 January 2021

Efficacy and safety of vaccination of marrow transplant recipients with a live attenuated measles, mumps, and rubella vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2899%2900070-0

7 January 2021

Mumps prophylaxis in the light of a new test for antibody

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2899%2900070-0

7 January 2021

Human parvovirus (B19) and erythema infectiosum

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2899%2900070-0

7 January 2021

Seroepidemiology of human herpesvirus 6 infection in normal children and adults

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2899%2900070-0

7 January 2021

Seroepidemiology of human herpesvirus-6 in pregnant women from different parts of the world

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2899%2900070-0

7 January 2021

Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2899%2900070-0

7 January 2021

Seroprevalence of human parvovirus B19 infection in Sao Tomé and Principe, Malawi and Mascarene Islands

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2899%2900070-0

7 January 2021

Identification of human herpesvirus-6 as a causal agent for exanthem subitum

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2899%2900070-0

7 January 2021

10.1016/S1386-6532(99)00070-0

Identifiers

DOI

1 reference

23 December 2017

1 reference

23 December 2017